(ORDO NEWS) — Elon Musk has repeatedly promised that his company Neuralink, which develops interface technology for working with the brain, will soon begin clinical trials in humans.
True, it recently became known that Musk forgot to mention one detail – Neuralink already applied for the start of human trials of brain chips, back in 2022, but the US regulators rejected this application.
Neuralink filed an application with the U.S. Food and Drug Administration in early 2022, according to Reuters.
However, the application was rejected, with Neuralink employees saying that regulators had identified dozens of issues that needed to be addressed first, as well as raised concerns about the safety of the company’s plans to implant the chips in humans.
Neuralink employees doubt that the company will be able to solve the problems that have arisen in the near future in order to meet Musk’s ambitious deadlines.
So, Elon Musk promised that human trials of Neuralink would begin at least in 2019.
In 2020, he promised that trials of a coin-sized brain chip designed to allow disabled patients to move and communicate again would begin “in less than a year.”
In February 2021, he wrote that the company is working with regulatory authorities to achieve “human trials later this year.” About ten months later, Musk’s schedule shifted to “next year.”
—
Online:
Contact us: [email protected]
Our Standards, Terms of Use: Standard Terms And Conditions.